Wednesday, 30 November 2016 - Paris, Renaissance Paris La Defense Hotel
Official language: French (Please note that presentations marked with * will be in English. View the Agenda)
The role that patient can play in helping biotechnology and pharmaceutical development has recently grown up exponentially.
Patient are better informed about medical information and much more aware of their treatment options.
A collaborative scenario between pharmaceutical companies, patient advocacy groups, regulators and innovation technology, could result in the faster delivery of medicines to patient, also with a positive impact on the industries.
The conference will address through the context of clinical trials with reference to:
The context of Medical Affairs and Legal Affairs will also be analyzed, focusing on the roles and activities of patient oriented medical affairs and on the legal implication in the communication between patient and industries.
Anna Cali, Toujeo Global Medical Lead, Medical Affair Diabetes Division, Sanofi
Erick Gaussens, Principal Consultant, ProductLife Group
Bertrand Sohier, Senior Medical Director Global Head, Respiratory, Critical Care, Cardiovascular and endocrinology Therapeutic Areas, PAREXEL
The conference is addressed to all the Clinical Research Professionals, belonging to the following departments:
Clinical Operations and Medical Affairs
Statistics and Data Management
from Pharmaceutical and Biotechnology companies, Clinical Research Organizations, Academic Centres, Hospital Centres, and Clinical Technology companies.